Since COVID-19 first spread rapidly around the world in 2020, we have significantly more options to reduce the symptoms and severity of the virus. COVID-19 symptoms usually begin in the first five days after exposure and ...
Nov 28, 2023
0
1
A large proportion of patients who start taking ADHD medication, especially young adults, stop within the first year. However, people who use ADHD medicine for a long time and in higher-than-average doses seem to have a higher ...
Nov 28, 2023
0
27
Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full dose with fewer side effects, according to a new study.
Nov 24, 2023
0
47
Two new gene-editing treatments that target dangerously high levels of cholesterol in people with a genetic predisposition to the condition were found safe and effective in new, groundbreaking research.
Nov 18, 2023
0
1
The American Society for Radiation Oncology (ASTRO) issued today a clinical guideline on partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ (DCIS). For the guideline, ...
Nov 15, 2023
0
0
For more than 50 years, the conventional wisdom in the field of research in cocaine use has been that people take cocaine based on the theory of the drug providing positive reinforcement to the user.
Nov 15, 2023
0
31
A new study led by Professor Laura Magee, has found that among pregnancies with clinical risk factors for pre-eclampsia or fetal growth restriction, measuring serum placental growth factor (PlGF) at the time of the routine ...
Nov 14, 2023
0
0
The nuclear accident in Chernobyl in 1986 led to the spread of radioactivity across Sweden and Europe. In a long-term study now published in Environmental Epidemiology, researchers have used new, more specific calculation ...
Nov 13, 2023
0
0
As COVID and its health effects move into a fourth year, those who become infected may be searching for remedies to improve their respiratory symptoms and keep them out of the hospital.
Nov 9, 2023
0
36
A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including gout, heart failure, cardiomyopathy, and atrial fibrillation, say scientists ...
Nov 1, 2023
0
73
